Cargando…
A high-throughput screening assay for eukaryotic elongation factor 2 kinase inhibitors
Eukaryotic elongation factor 2 kinase (eEF2K) inhibitors may aid in the development of new therapeutic agents to combat cancer. Purified human eEF2K was obtained from an Escherichia coli expression system and a luminescence-based high-throughput screening (HTS) assay was developed using MH-1 peptide...
Autores principales: | Xiao, Ting, Liu, Rui, Proud, Christopher G., Wang, Ming-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071636/ https://www.ncbi.nlm.nih.gov/pubmed/27818922 http://dx.doi.org/10.1016/j.apsb.2016.04.002 |
Ejemplares similares
-
Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer
por: Wang, Xuemin, et al.
Publicado: (2017) -
Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase
por: Pyr Dit Ruys, Sébastien, et al.
Publicado: (2012) -
Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase
por: Ruys, S. Pyr Dit, et al.
Publicado: (2012) -
Eukaryotic elongation factor 2 kinase regulates the synthesis of microtubule‐related proteins in neurons
por: Kenney, Justin W., et al.
Publicado: (2015) -
Impairing Eukaryotic Elongation Factor 2 Kinase Activity Decreases Atherosclerotic Plaque Formation
por: Zhang, Peng, et al.
Publicado: (2014)